FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei.

Eur J Nucl Med Mol Imaging

Nuclear Medicine and PET Unit, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, 165 Chemin du Grand Revoyet, 69495, Pierre-Bénite, France.

Published: August 2016

AI Article Synopsis

  • Pseudomyxoma peritonei (PMP) is a rare cancer linked to appendiceal tumors, and this study aimed to assess the effectiveness of FDG-PET/ceCT scans in predicting patient outcomes, specifically progression-free survival (PFS).
  • The study included 56 patients who underwent surgery and chemotherapy for PMP, evaluating FDG-PET/ceCT scans and correlating results with clinical parameters like the Peritoneal Cancer Index (PCI) and Completeness of Cytoreduction Score (CCR).
  • Findings revealed that SUVmax (a PET scan measurement) was an independent predictor for PFS but did not show a significant connection to post-operative CCR or differences based on disease spread type. Further research

Article Abstract

Purpose: Pseudomyxoma peritonei (PMP) is a rare peritoneal neoplasm originating from appendicular tumours. There is no consolidated data available in the literature about the precise role of [(18)F] fluorodesoxy-D-glucose Positron Emission Tomography / contrast enhanced Computed Tomography (FDG-PET/ceCT). The aim of this study was to evaluate the correlation between preoperative FDG-PET/ceCT (qualitative and semi-quantitative assessment) and progression free survival (PFS) of patients treated for PMP.

Methods: All patients scheduled for PMP treatment by cytoreductive unicentric surgery, intraperitoneal chemotherapy (HIPEC), and who underwent a FDG-PET/ceCT between February 2008 and January 2014, were included. No previous treatment was performed (except biopsy or appendectomy). FDG-PET/ceCT was interpreted by two nuclear physicians in consensus. Positive FDG-PET/ceCT scans were further labelled in diffuse disease and poly/mono focal disease. SUVmax was measured based on post-operative reports. The Peritoneal Cancer Index (PCI) and Completeness of CytoReduction Score (CCR) were assessed after surgery.

Results: Fifty-six patients were included in this study, with a mean age of 56-years-old and a mean follow-up of 29.3 months. SUVmax, with a cut-off at 2.02, was predictive for the PFS on multivariate analysis. No differences were observed between diffuse disease and focal disease on PFS for progression free survival, PCI, and SUVmax (p = 0.1). Post-operative CCR was not significantly correlated with SUVmax or FDG-PET/ceCT qualitative assessment.

Conclusion: SUVmax on preoperative FDG-PET/ceCT was an independent predictive factor for PFS in PMP. Further studies are needed to explore if FDG-PET/ceCT could potentially predict post-operative CCR.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-016-3347-zDOI Listing

Publication Analysis

Top Keywords

fdg-pet/cect
9
fdg-pet/cect predict
8
pseudomyxoma peritonei
8
preoperative fdg-pet/cect
8
fdg-pet/cect qualitative
8
progression free
8
free survival
8
diffuse disease
8
focal disease
8
post-operative ccr
8

Similar Publications

Background: The clinicoradiological staging for esophageal cancer is fraught with variable accuracy, potentially depriving patients who have been understaged of the benefit of neoadjuvant therapy, which has been shown to improve long-term survival in locally advanced malignancies. It is imperative to identify these high-risk tumors for tailored treatment.

Methods: Retrospective analysis of a prospective database of patients undergoing esophagectomy for carcinoma esophagus between 2011 and 2019.

View Article and Find Full Text PDF
Article Synopsis
  • * A case study details a 14-year-old boy with HBV who developed multinational HCC, presenting symptoms like abdominal distension and jaundice and confirmed through CECT and histopathology.
  • * The child's presentation mirrored that of adults, with risk factors including viral hepatitis and male gender; notably, he had no previous signs of liver issues before being diagnosed.
View Article and Find Full Text PDF
Article Synopsis
  • A study conducted at Dr. Khuroo's Medical Clinic in Kashmir identified 12 cases of Alveolar echinococcosis (AE) among 110 patients, primarily affecting middle-aged individuals with a history of abdominal pain, highlighting liver involvement.
  • The tumors observed in patients showed significant invasion into nearby structures and were characterized by specific histological features typical of AE.
  • Treatment varied, with some patients undergoing surgery or being treated with chemotherapy, resulting in clinical improvements, though follow-up imaging revealed persistent disease in some cases.
View Article and Find Full Text PDF

Diagnostic Performance of Response Assessment FDG-PET/CECT in HNSCC Treated With Definitive Radio(chemo)therapy Using NI-RADS.

Otolaryngol Head Neck Surg

October 2023

Department of Radiation Oncology, Tata Memorial Hospital (TMH)/Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.

Objective: To assess the diagnostic performance of response assessment 18F-fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography (FDG-PET/CECT) following definitive radio(chemo)therapy in head and neck squamous cell carcinoma (HNSCC) using Neck Imaging Reporting and Data System (NI-RADS).

Study Design: A retrospective analysis from a prospectively maintained dataset.

Setting: Tertiary-care comprehensive cancer center in a low-middle-income country.

View Article and Find Full Text PDF

We describe the 18F-fluorodeoxyglucose positron emission tomography/contrast enhanced computed tomography (FDG PET/CECT) images of a 63-year-old male who complained of back pain and was suspected of multiple myeloma based on magnetic resonance imaging. PET/CECT suggested the FDG avid lesion involving prostate, accompanied by multiple lytic skeletal lesions with no evidence to suggest other possible primary site. A bone marrow biopsy suggested a metastatic adenocarcinoma of primary prostatic origin.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!